Back to top
more

Integer Holdings (ITGR)

(Delayed Data from NYSE)

$131.49 USD

131.49
142,722

-0.94 (-0.71%)

Updated Oct 15, 2024 04:00 PM ET

After-Market: $131.54 +0.05 (0.04%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value B Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 33% (82 out of 250)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Zacks Industry Outlook Highlights Hologic, Masimo and Integer

by Zacks Equity Research

Hologic, Masimo and Integer have been highlighted in this Industry Outlook article.

Urmimala Biswas headshot

3 Medical Instruments Stocks to Buy Amid Industry Challenges

by Urmimala Biswas

The Zacks Medical - Instruments industry is growing on rising demand for digital health. HOLX, MASI and ITGR are set to gain the most. Yet, ongoing inflation, in the form of rising freight and raw material costs, is disrupting the trend.

ITGR vs. EW: Which Stock Is the Better Value Option?

by Zacks Equity Research

ITGR vs. EW: Which Stock Is the Better Value Option?

Integer Holdings (ITGR) Q1 Earnings, Revenues Beat Estimates

by Zacks Equity Research

Integer Holdings' (ITGR) first-quarter results reflect robust Medical and Non-Medical sales, besides strength in all the product lines.

Integer (ITGR) Surpasses Q1 Earnings and Revenue Estimates

by Zacks Equity Research

Integer (ITGR) delivered earnings and revenue surprises of 6.10% and 7.85%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Integer (ITGR) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

Integer (ITGR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Strength Seen in LivaNova (LIVN): Can Its 12.7% Jump Turn into More Strength?

by Zacks Equity Research

LivaNova (LIVN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Intuitive Surgical (ISRG) to Post Q1 Earnings: What's in Store?

by Zacks Equity Research

Intuitive Surgical's (ISRG) first-quarter results likely to reflect solid performance in the Instruments & Accessories segment. However, rising costs may have hurt margins.

Treace Medical Concepts (TMCI) Surges 7.6%: Is This an Indication of Further Gains?

by Zacks Equity Research

Treace Medical Concepts (TMCI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

3 Reasons to Retain Integer Holdings (ITGR) Stock for Now

by Zacks Equity Research

Investors continue to be optimistic about Integer Holdings (ITGR) owing to its improving non-medical sales and a solid foothold in the broader MedTech space.

Integer Holdings (ITGR) Q4 Earnings Beat Estimates, Margins Up

by Zacks Equity Research

Integer Holdings' (ITGR) fourth-quarter results reflect robust Medical and Non-Medical Sales, besides strength in all the product lines.

Integer (ITGR) Beats Q4 Earnings and Revenue Estimates

by Zacks Equity Research

Integer (ITGR) delivered earnings and revenue surprises of 5.71% and 1.58%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Indrajit Bandyopadhyay headshot

Medical Device Stocks' Q4 Earnings on Feb 16: WST, SWAV & More

by Indrajit Bandyopadhyay

Medical Device players are likely to have benefited from the reopening of economies and several efforts to combat macro headwinds. Let's see how WST, SWAV, AMN, ITGR and PACB are likely to fare this time.

Integer Holdings (ITGR) Announces Solid Preliminary Q4 Revenues

by Zacks Equity Research

Integer Holdings' (ITGR) revenue growth in the fourth quarter is likely to have been boosted by continued strong customer demand for its products.

Intuitive Surgical, Inc. (ISRG) Q4 Earnings Miss Estimates

by Zacks Equity Research

Intuitive Surgical, Inc. (ISRG) delivered earnings and revenue surprises of -2.38% and 0%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Integer Holdings (ITGR) Q3 Earnings Beat, 2022 View Lowered

by Zacks Equity Research

Integer Holdings' (ITGR) third-quarter results reflect robust Medical and Non-Medical Sales, besides strength in all the product lines.

Integer (ITGR) Surpasses Q3 Earnings Estimates

by Zacks Equity Research

Integer (ITGR) delivered earnings and revenue surprises of 6.74% and 0.14%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Idexx Laboratories (IDXX) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

Idexx (IDXX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Integer (ITGR) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Integer (ITGR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Here's Why You Should Retain Integer Holdings (ITGR) Stock Now

by Zacks Equity Research

Integer Holdings (ITGR) continues to gain momentum from robust medical sales and a solid foothold in the broader MedTech space. However, intense competition persists.

Integer Holdings (ITGR) Q2 Earnings Miss, FY22 View Revised

by Zacks Equity Research

Integer Holdings' (ITGR) second-quarter results reflect robust Medical Sales besides strength in the majority of product lines.

Integer (ITGR) Q2 Earnings Miss Estimates

by Zacks Equity Research

Integer (ITGR) delivered earnings and revenue surprises of -11.86% and 1.41%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Here's Why You Should Retain Integer Holdings (ITGR) Stock Now

by Zacks Equity Research

Integer Holdings (ITGR) continues to gain momentum from improving non-medical sales and a solid foothold in the broader MedTech space. However, intense competition persists.

Reasons to Retain Integer Holdings (ITGR) Stock For Now

by Zacks Equity Research

Investors continue to be optimistic about Integer Holdings (ITGR) owing to its improving non-medical sales and solid foothold in the broader MedTech space.

Integer Holdings (ITGR) Q1 Earnings, Revenues Lag Estimates

by Zacks Equity Research

Integer Holdings' (ITGR) first-quarter results reflect robust segmental performances besides strength in the majority of the product lines.